Patent details
EP3681505 Title: IMPROVED TREATMENT OF ATOPIC DERMATITIS WITH TRADIPITANT
Basic Information
- Publication number:
- EP3681505
- PCT Application Number:
- US2018048825
- Type:
- European Patent Granted for LU
- Legal Status:
- Unitary Effect Registered
- Application number:
- EP187786355
- PCT Publication Number:
- WO2019055225
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- IMPROVED TREATMENT OF ATOPIC DERMATITIS WITH TRADIPITANT
- French Title of Invention:
- TRAITEMENT AMÉLIORÉ DE LA DERMATITE ATOPIQUE UTILISANT DU TRADIPITANT
- German Title of Invention:
- VERBESSERTE BEHANDLUNG VON ATOPISCHER DERMATITIS MIT TRADIPITANT
- SPC Number:
Unitary Effect
- Unitary Effect Requested:
- Yes
- Unitary Effect Request Filing Date:
- 15/01/2025
- Link to UPP Register:
- European Patent Register
- Unitary Effect Request Withdrawal Date:
- Unitary Effect Status:
- Unitary Effect Registered
- Unitary Effect Acceptance Decision Date:
- 22/01/2025
- Unitary Effect Rejection Decision Date:
- Unitary Effect Date:
- 18/12/2024
- Unitary Effect Registration Date:
- 22/01/2025
- Unitary Effect Re-establishment of rights Filing Date:
- Unitary Effect Re-establishment of rights EPO Decision :
- Unitary Effect Re-establishment of rights EPO Decision Date:
- Explanatory Text UE:
- Safety Net Request Date:
- Safety Net Decision Date:
- Safety Net Decision Outcome:
- SPC Number:
Dates
- Filing date:
- 30/08/2018
- Grant date:
- 18/12/2024
- EP Publication Date:
- 22/07/2020
- PCT Publication Date:
- 21/03/2019
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 18/12/2024
- EP B1 Publication Date:
- 18/12/2024
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- Expiration date:
- 30/08/2038
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 11/12/2024
- Name:
- Vanda Pharmaceuticals Inc.
- Address:
- 2200 Pennsylvania Ave NW Suite 300-E, Washington, DC 20037, United States (US)
Inventor
1
- Name:
- HEITMAN, Andrew
- Address:
- United States (US)
2
- Name:
- POLYMEROPOULOS, Mihael, H.
- Address:
- United States (US)
3
- Name:
- BIRZNIEKS, Gunther
- Address:
- United States (US)
4
- Name:
- SMIESZEK, Sandra
- Address:
- United States (US)
5
- Name:
- XIAO, Changfu
- Address:
- United States (US)
Priority
1
- Priority Number:
- 201762558303 P
- Priority Date:
- 13/09/2017
- Priority Country:
- United States (US)
2
- Priority Number:
- 201762572456 P
- Priority Date:
- 14/10/2017
- Priority Country:
- United States (US)
Classification
- IPC classification:
- A61K 31/5377; A61P 17/04;
Publication
European Patent Bulletin
1
- Issue number:
- 202451
- Publication date:
- 18/12/2024
- Description:
- Grant (B1)
2
- Issue number:
- 202508
- Publication date:
- 19/02/2025
- Description:
- Unitary Effect Request Receipt
3
- Issue number:
- 202509
- Publication date:
- 26/02/2025
- Description:
- Unitary Effect Request Acceptance
Annual Fees
- Annual Fee Due Date:
- Annual Fee Number:
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|